Search

García-Posadas, Hodges, Li, Shatos, Storr-Paulsen, Diebold, and Dartt. 2016. “Interaction of IFN-γ With Cholinergic Agonists to Modulate Rat and Human Goblet Cell Function.”. Mucosal Immunol 9 (1): 206-17.

Silva, Paolo, and Lloyd Paul Aiello. 2015. “Reply.”. Retina 35 (7): e37-8.

Joshi, Peter, Tonu Esko, Hannele Mattsson, Niina Eklund, Ilaria Gandin, Teresa Nutile, Anne Jackson, et al. 2015. “Directional Dominance on Stature and Cognition Indiverse Human Populations.”. Nature 523 (7561): 459-62.

Reddy, Ashvini, Marco Gonzalez, Christopher Henry, Steven Yeh, Lucia Sobrin, and Thomas Albini. 2015. “Diagnostic Sensitivity of Indocyanine Green Angiography for Birdshot Chorioretinopathy.”. JAMA Ophthalmol 133 (7): 840-3.

Yu, Dekuang, Jin Zheng, Ruilin Zhu, Nan Wu, Alex Guan, Kin-Sang Cho, Dong Feng Chen, and Gang Luo. 2015. “Computer-Aided Analyses of Mouse Retinal OCT Images - an Actual Application Report.”. Ophthalmic Physiol Opt 35 (4): 442-9.

Tandon, Arti, Ching Chen, Alan Penman, Heather Hancock, Maurice James, Deeba Husain, Christopher Andreoli, et al. 2015. “African Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans.”. Invest Ophthalmol Vis Sci 56 (6): 3999-4005.

Choi, Hee Joo, Daniel Sun, and Tatjana Jakobs. 2015. “Isolation of Intact Astrocytes from the Optic Nerve Head of Adult Mice.”. Exp Eye Res 137: 103-10.

McAlvin, James Brian, Changyou Zhan, Jenny Dohlman, Paraskevi Kolovou, Borja Salvador-Culla, and Daniel Kohane. 2015. “Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.”. Invest Ophthalmol Vis Sci 56 (6): 3820-6.

Silva, Paolo, Jerry Cavallerano, Ann Tolson, Jessica Rodriguez, Sashida Rodriguez, Radwan Ajlan, Dorothy Tolls, et al. 2015. “Real-Time Ultrawide Field Image Evaluation of Retinopathy in a Diabetes Telemedicine Program.”. Diabetes Care 38 (9): 1643-9.

Kruh, Jonathan, Nicole Kruh-Garcia, and Stephen Foster. 2015. “Evaluation of the Effect of N-Acetylcysteine on Protein Deposition on Contact Lenses in Patients With the Boston Keratoprosthesis Type I.”. J Ocul Pharmacol Ther 31 (6): 314-22.